Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
136.7%
-
Total 13F principal
-
$323,575,772
-
Principal change
-
-$67,699,767
-
Total reported market value
-
$449,899,146
-
Number of holders
-
43
-
Value change
-
-$92,665,808
-
Number of buys
-
13
-
Number of sells
-
24
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q4 2014
As of 31 Dec 2014,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
43 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$323,575,772
in principal (par value) of the bond.
The largest 10 bondholders included
ZAZOVE ASSOCIATES LLC, MACKAY SHIELDS LLC, Invesco Ltd., CREDIT SUISSE AG/, Thrivent Financial for Lutherans, VICTORY CAPITAL MANAGEMENT INC, BNP Paribas Investment Partners S.A., PALISADE CAPITAL MANAGEMENT LLC/NJ, INCOME RESEARCH & MANAGEMENT, and Calamos Advisors LLC.
This page lists
43
institutional bondholders reporting positions
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.